Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
38.28
-0.02 (-0.05%)
At close: Apr 1, 2026, 4:00 PM EDT
37.97
-0.31 (-0.81%)
After-hours: Apr 1, 2026, 6:12 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $2.06 billion as of April 1, 2026. Its market cap has increased by 264.99% in one year.
Market Cap
2.06B
Enterprise Value
1.81B
1-Year Change
264.99%
Ranking
Category
Stock Price
$38.28
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $2.06B, an increase of 214.99%. That is a compound annual growth rate of 28.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 2.06B | 47.03% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.17B |
| ADMA Biologics | 2.15B |
| Syndax Pharmaceuticals | 2.10B |
| Ultragenyx Pharmaceutical | 2.09B |
| Celldex Therapeutics | 2.08B |
| Aurinia Pharmaceuticals | 2.04B |
| Definium Therapeutics | 2.02B |
| Mesoblast | 2.01B |